Back
Cidara Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
69
CDTX
Cidara Therapeutics
Last Price:
$52.27
Seasonality Move:
-8.55%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cidara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.28 | Buy |
| 20-day SMA: | 45.38 | Buy |
| 50-day SMA: | 31.93 | Buy |
| 200-day SMA: | 22.25 | Buy |
| 8-day EMA: | 51.05 | Buy |
| 20-day EMA: | 45.48 | Buy |
| 50-day EMA: | 36.04 | Buy |
| 200-day EMA: | 24.52 | Buy |
Cidara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.43 | Buy |
| Relative Strength Index (14 RSI): | 70.84 | Buy |
| Chaikin Money Flow: | 335291 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.7 - 53.64) | Buy |
| Bollinger Bands (100): | (15.82 - 37.24) | Buy |
Cidara Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 52.26 while CDTX 8-day simple moving average is 51.28, which is a Buy signal.
-
The stock price of CDTX is 52.26 while Cidara Therapeutics 20-day SMA is 45.38, which makes it a Buy.
-
Cidara Therapeutics 50-day simple moving average is 31.93 while CDTX share price is 52.26, making it a Buy technically.
-
CDTX stock price is 52.26 and Cidara Therapeutics 200-day simple moving average is 22.25, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
69
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a BuyThe current Cidara Therapeutics [CDTX] share price is $52.26. The Score for CDTX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
1.2B
Price in USD:
52.26
Share Volume:
437.1K
Cidara Therapeutics 52-Week Range
52-Week High:
56.83
52-Week Low:
10.14
Buy
69
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?The Cidara Therapeutics stock price is 52.26 USD today.
-
Will CDTX stock go up or go down?Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cidara Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 52.26 while CDTX 8-day exponential moving average is 51.05, which is a Buy signal.
-
The stock price of CDTX is 52.26 while Cidara Therapeutics 20-day EMA is 45.48, which makes it a Buy.
-
Cidara Therapeutics 50-day exponential moving average is 36.04 while CDTX share price is 52.26, making it a Buy technically.
-
CDTX stock price is 52.26 and Cidara Therapeutics 200-day simple moving average is 24.52, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
-
CDTX Moving Average Covergence Divergence (MACD) indicator is 6.43, suggesting Cidara Therapeutics is a Buy
-
Cidara Therapeutics Relative Strength Index (RSI) is 70.84, which suggest Cidara Therapeutics is overbought
-
The Bollinger Bands (25) for Cidara Therapeutics is (28.7 - 53.64), which suggest Cidara Therapeutics is a Buy
-
The Bollinger Bands (100) for Cidara Therapeutics is (15.82 - 37.24), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.